| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0009609> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0013125> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0015620> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0026344> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0033607> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0042774> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0206750> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0678119> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0682972> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0733580> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0733581> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C0949471> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C2936405> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C3489666> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C3494273> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C3494274> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C3661486> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C3694279> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/32599963_HAS_TOPIC_C5392994>
?:authorAffiliation	[\'Department of Pharmacology, Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.\', \'Unidad de Química Medicinal, Facultad de Farmacia, Universidad Central de Venezuela, Caracas 1041-A, Venezuela.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Jastrzebska_Beata> <https://research.tib.eu/covid-19/entity/Ortega_Joseph_T> <https://research.tib.eu/covid-19/entity/Serrano_Maria_Luisa>
?:doi	E95410.3390/biom10060954
?:doi	<https://research.tib.eu/covid-19/entity/E95410.3390/biom10060954>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Biomolecules
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32599963>
?:pmid	<https://research.tib.eu/covid-19/entity/32599963>
?:pmid	32599963
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.552
?:rankingScore_hIndex	28
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0012634_COEXISTS_WITH_C0425946> <https://research.tib.eu/covid-19/entity/C0015620_INHIBITS_C0030940> <https://research.tib.eu/covid-19/entity/C0015620_INHIBITS_C0682972> <https://research.tib.eu/covid-19/entity/C0015620_INTERACTS_WITH_C0030946> <https://research.tib.eu/covid-19/entity/C0030940_AFFECTS_C0042774>
?:title	Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C0332486>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C0332486>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all